ISPOR Europe 2022

The OHE team will be attending ISPOR Europe 2022, with many involved in sessions throughout the event.

If you are attending and would like to meet any of the team, please come along to one of our sessions or you can contact our experts individually via LinkedIn or the conference system.

OVERVIEW OF OHE at ISPOR Europe
NAME DATE AND TIME TITLE SESSION LOCATION
DAVID MOTT
(SPEAKER)
7th Nov 10:15 - 11:15 CET
Modelling Spillover Effects on Informal Carers: The 'Carer QALY Trap' 
 
Podium Sessions: 110 HEOR Theater 2, Hall X1, L-2
LOTTE STEUTEN (SPEAKER) 7th Nov 11:45 - 12:45 CET
Improving HEOR Methods for the Implementation of Value-Based Healthcare Projects
 
ISPOR Forums: 116 Hall F1, L0
LOTTE STEUTEN (DISCUSSION LEADER) 7th Nov 13:30 -14:30 CET
Real-world data at scale: How machine learning can enable learning from all patients
 
Concurrent Breakout Session 2: 128 Hall E2, L0
LOTTE STEUTEN 7th Nov 15:00 - 18:15 CET
Impact of Modelling the Inclusion of Productivity Losses in Economic Analyses of Vaccines for Clostridioides Difficile Infections and Respiratory Syncytial Virus
 
Poster Session 2: EE24 Hall X2, L-2
ELEANOR BELL 7th Nov 15:00 - 18:15 CET
Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines
 
Poster Session 2: HPR63 Hall X2, L-2
EDWARD OLIVER 7th Nov 15:00 - 18:15 CET
The Value of Next Generation Sequencing for Lung Cancer in Europe: Findings From a Literature Review
 
Poster Session 2: MT17 Hall X2, L-2
CHRIS SAMPSON
(MODERATOR)
7th Nov 16:30 - 17:30 CET
Are Open-Source Models Really for Health Technology Assessment and Health Policy?
 
Concurrent Breakout Session 3: 139 Hall F2, L0
CHRIS SAMPSON
​(MODERATOR)
7th Nov 17:45 - 18:30 CET
Open-Source Model Discussion Group
 
Discussion Group Session: 151 Discussion Lounge, Hall X1, L-2
SIAN BESLEY 8th Nov 10:00 - 13:15 CET
Healthcare Systems Sustainability and Resilience: Creating an Index
 
Poster Session 3: EPH118 Hall X2, L-2
ADRIAN TOWSE (MODERATOR) & AMANDA COLE (SPEAKER) 8th Nov 11:30 -12:30 CET
Gene Therapies: Where High Promise Meets High Uncertainty, How Should HTA Methodologies Appropriately Value and Enable Access?
 
Educational Symposia: 210 Hall E2, L0 - sponsor Pfizer
ADRIAN TOWSE 8th Nov 13:30 -14:30 CET
How Should the EU Pull Their Weight? Designing and Implementing an Effective Delinked Pull Incentive for Antibiotics in the EU
 
Concurrent Breakout Session 5: 221 Hall F1, L0
MIREIA JOFRE-BONNET 8th Nov 14:00 -14:45 CET
Meet and Greet Event for ISPOR Faculty Leadership and Advisors
 
  X3 Hall Booth 200
LOTTE STEUTEN (MODERATOR) & SIMON BRASSEL (SPEAKER) 8th Nov 15:00 -16:00 CET
Are We Turning a Blind Eye? Challenges in Value Assessment of Gene Therapies for Inherited Retinal Disease
 
Educational Symposia: 231 Hall E1, L0
LOTTE STEUTEN
(SPEAKER)
8th Nov 15:30 - 16:30 CET
Women in HEOR: Achievements, Lessons Learned and Future Ambitions
 
Concurrent Breakout Session 6: 245 HEOR Theater 1, Hall X3, L-2
MIKEL BERDUD 9th Nov 09:30 - 12:30 CET
The Basis for a New Framework to Determine the Cost-Effectiveness Threshold
 
Poster Session 5: EE664 Hall X2, L-2
SIMON BRASSEL 9th Nov 09:30 - 12:30 CET
The International Impact of National Institute for Health and Care Excellence (NICE) Decisions
 
Poster Session 5: HPR185 Hall X2, L-2
CHRIS SKEDGEL 9th Nov 10:00 - 11:00 CET
Should Payers Increase Reimbursement for Treatments for Severe Diseases? Empirical Approaches for Estimating Risk Preferences with Applications to Grace and Insurance Value
 
Concurrent Breakout Session 8: 313 Hall N, L1

 

Sunday, 6 November 2022 to Wednesday, 9 November 2022